We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Looks to Its Pipeline for Earnings Growth in 2007
Merck Looks to Its Pipeline for Earnings Growth in 2007
December 12, 2006
Merck expects its drug development pipeline, including three expected new drug applications (NDAs) in 2007, to contribute to high earnings growth, the company announced.